GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Financial Strength

Novan (NOVNW) Financial Strength : 0 (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Novan Financial Strength?

Novan has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Novan did not have earnings to cover the interest expense. Novan's debt to revenue ratio for the quarter that ended in Mar. 2023 was 0.32. As of today, Novan's Altman Z-Score is -6.81.


Competitive Comparison of Novan's Financial Strength

For the Biotechnology subindustry, Novan's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novan's Financial Strength Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novan's Financial Strength distribution charts can be found below:

* The bar in red indicates where Novan's Financial Strength falls into.


;
;

Novan Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Novan's Interest Expense for the months ended in Mar. 2023 was $-0.28 Mil. Its Operating Income for the months ended in Mar. 2023 was $-13.47 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $3.39 Mil.

Novan's Interest Coverage for the quarter that ended in Mar. 2023 is

Novan did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Novan's Debt to Revenue Ratio for the quarter that ended in Mar. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.465 + 3.387) / 11.984
=0.32

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Novan has a Z-score of -6.81, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of -6.81 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novan  (OTCPK:NOVNW) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Novan has the Financial Strength Rank of 0.


Novan Financial Strength Related Terms

Thank you for viewing the detailed overview of Novan's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Novan, Inc. - Special Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report Full Year 2022 Financial Results on March 30, 2023

By sperokesalga sperokesalga 03-23-2023

Novan Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024